← Back
Data updated: Mar 10, 2026
TALICIA HOLDINGS
Infectious Disease
TALICIA HOLDINGS is a pharmaceutical company focused on Infectious Disease. Key products include TALICIA.
2019
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2019-11-01
- Latest
- 2024-05-01
- Applications
- 1